New ‘Self-Amplifying’ RNA-Based Vaccine: Progress or Possible Problems?
This month, the approval of an RNA-based vaccine for COVID-19 took another step forward with the endorsement last week by Japanese...
Read moreDetailsThis month, the approval of an RNA-based vaccine for COVID-19 took another step forward with the endorsement last week by Japanese...
Read moreDetailsAgroforestry techniques popularized by APAF, a network of associations specializing in the extension of agroforestry techniques to African farmers, reverse...
Read moreDetailsThe European Investment Bank's (EIB) Board of Directors has approved this week a €5 billion project designed to support manufacturers...
Read moreDetailsThis week, in the context of the 28th UN Climate Change Conference (COP28) in the United Arab Emirates, the United...
Read moreDetailsTesla will recall over two million cars from the American market. That’s almost all Teslas in the United States. Why...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.